Backbone modification of a polypeptide drug alters duration of action in vivo.
Backbone modification of a polypeptide drug alters duration of action in vivo.
复制标题
DOI:
10.1038/nbt.2920
复制
发表时间:
2014-07
影响因子:
46.9
通讯作者:
Gellman, Samuel H.
中科院分区:
文献类型:
--
作者:
Cheloha, Ross W.;Maeda, Akira;Dean, Thomas;Gardella, Thomas J.;Gellman, Samuel H.
Systematic modification of the backbone of bioactive polypeptides through β-amino acid residue incorporation could provide a strategy for generating molecules with improved drug properties, but such alterations can result in lower receptor affinity and potency. Using an agonist of parathyroid hormone receptor-1 (PTHR1), a G protein–coupled receptor in the B-family, we present an approach for α→β residue replacement that enables both high activity and improved pharmacokinetic properties in vivo.
登录
查看更多内容
影响因子:
--
作者:
Johnson, Lisa M.;Gellman, Samuel H.
通讯作者:
Gellman, Samuel H.
影响因子:
4
作者:
Binkowski, Brock F.;Butler, Braeden L.;Wood, Keith V.
通讯作者:
Wood, Keith V.
DOI:
10.1073/pnas.0801027105
发表时间:
2008-04-01
影响因子:
11.1
作者:
Pioszak, Augen A.;Xu, H. Eric
通讯作者:
Xu, H. Eric
DOI:
10.1073/pnas.0808750105
发表时间:
2008-10-28
影响因子:
11.1
作者:
Okazaki, Makoto;Ferrandon, Sebastien;Gardella, Thomas J.
通讯作者:
Gardella, Thomas J.
DOI:
10.1073/pnas.0902663106
发表时间:
2009-09-01
影响因子:
11.1
作者:
Horne, W. Seth;Johnson, Lisa M.;Gellman, Samuel H.
通讯作者:
Gellman, Samuel H.